Flucoric

C₁₃H₁₂F₂N₆O306.27 g/mol

2-(2,4-Difluorophenyl)-1,3-bis(1,2,4-triazol-1-yl)propan-2-ol

Drag to rotate; arrow keys step through the atoms. Structure from PubChem CID 3365.

Registration

Applicants: 2
Registrations: 5

Applicants and registrations

Applicant	Brands	Dosages	Registrations	Schedule	Leaflets
Ranbaxy (SA) (Pty) Ltd	Flucoric	50, 100, 150, 200	370114, 370115, 370116, 370117	Not determined	PI PIL
Ranbaxy Pharmaceutical (Pty) LtdCancelled	Flucoric	infusion	440481	Not determined	None

Variants

Product	Strength and form	Registration	Status	Schedule	Leaflets
Flucoric 50 capsules EACH CAPSULE CONTAINS FLUCONAZOLE 50,0 mg	50Capsules	37011437/20.2.2/0114	Registered	Not determined	PI PIL
Flucoric 100 capsules EACH CAPSULE CONTAINS FLUCONAZOLE 100,0 mg	100Capsules	37011537/20.2.2/0115	Registered	Not determined	PI PIL
Flucoric 150 capsules EACH CAPSULE CONTAINS FLUCONAZOLE 150,0 mg	150Capsules	37011637/20.2.2/0116	Registered	Not determined	PI PIL
Flucoric 200 capsules EACH CAPSULE CONTAINS FLUCONAZOLE 200,0 mg	200Capsules	37011737/20.2.2/0117	Registered	Not determined	PI PIL
Flucoric infusion EACH 1,0 ml SOLUTIN CONTAINS FLUCONAZOLE 2,0 mg	Infusion	44048144/20.2.2/0481	Cancelled	Not determined	None

Regulatory status

This product is still scheduled by law even when this site could not determine which tier it falls under. The label carries the S number in a square border; ask a pharmacist if you need to know its schedule.

Listings for this ingredient that could not be applied to this product

S4: Fluconazole
- except as a single dose of 150 mg when indicated for the following fungal infections in adults
- Vaginal candidiasis, recurrent
- Candidial balanitis associated with vaginal candidiasis. (S2)
Consolidated Schedules 06 July 2026, lines 6351 to 6355
S2: Fluconazole
- as a single dose of 150 mg when indicated for the following fungal infections in adults:
- Vaginal candidiasis, recurrent
- Candidial balanitis associated with vaginal candidiasis.
Consolidated Schedules 06 July 2026, lines 1994 to 1998

This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.

Background

Loading Wikipedia summary

SAHPRA documents

Professional information (PI)For healthcare professionalsFlucoric 50 capsules, Ranbaxy (SA) (Pty) Ltd. SAHPRA's document for Flucoric Patient information leaflet (PIL)For patients and carersFlucoric 50 capsules, Ranbaxy (SA) (Pty) Ltd. SAHPRA's document for Flucoric

These documents come from SAHPRA's PI-PIL repository unless the line under a document says otherwise. Always consult with a healthcare professional for medical advice.

Research articles

Loading PubMed articles